levosulpiride and Neuroleptic-Malignant-Syndrome

levosulpiride has been researched along with Neuroleptic-Malignant-Syndrome* in 2 studies

Other Studies

2 other study(ies) available for levosulpiride and Neuroleptic-Malignant-Syndrome

ArticleYear
Levosulpiride associated neuroleptic malignant syndrome in an elderly patient: a tale of confusing brand names.
    Acta neurologica Belgica, 2022, Volume: 122, Issue:4

    Topics: Aged; Antipsychotic Agents; Humans; Neuroleptic Malignant Syndrome; Sulpiride

2022
Levosulpiride-induced neuroleptic malignant syndrome in rheumatoid arthritis.
    BMJ case reports, 2018, Aug-11, Volume: 2018

    A 53-year-old woman, known case of diabetes mellitus and rheumatoid arthritis, presented with a 4-day history of hyperthermia, rigidity, tremor and altered sensorium. She developed these symptoms after having been administered parenteral levosulpiride to control vomiting due to secondary adrenal insufficiency. We managed her as a case of life-threatening neuroleptic malignant syndrome (NMS) requiring mechanical ventilation, bromocriptine and other supportive care. She subsequently recovered and was discharged in a stable condition. To the best of our knowledge, this is the first documented case report describing levosulpiride-induced NMS.

    Topics: Adrenal Insufficiency; Antiemetics; Arthritis, Rheumatoid; Diagnosis, Differential; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Sulpiride; Vomiting

2018